First clinical isolate of Streptococcus pneumoniae exhibiting high-level resistance to fluoroquinolones in Taiwan

被引:4
作者
Hsueh, PR
Teng, LJ
Wu, TL
Ho, SW
Luh, KT
机构
[1] Natl Taiwan Univ, Coll Med, Sch Med Technol, Taipei, Taiwan
[2] Chang Gung Mem Hosp, Linkou, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
关键词
D O I
10.1093/jac/48.2.316
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:316 / 317
页数:2
相关论文
共 6 条
[1]   Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae [J].
Baranova, NN ;
Neyfakh, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1396-1398
[2]   Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae [J].
Brenwald, NP ;
Gill, MJ ;
Wise, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2032-2035
[3]   Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae [J].
Broskey, J ;
Coleman, K ;
Gwynn, MN ;
McCloskey, L ;
Traini, C ;
Voelker, L ;
Warren, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :95-99
[4]   High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA [J].
Janoir, C ;
Zeller, V ;
Kitzis, MD ;
Moreau, NJ ;
Gutmann, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2760-2764
[5]   Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season [J].
Jones, ME ;
Sahm, DF ;
Martin, N ;
Scheuring, S ;
Heisig, P ;
Thornsberry, C ;
Köhrer, K ;
Schmitz, FJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :462-466
[6]   Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae [J].
Pan, XS ;
Ambler, J ;
Mehtar, S ;
Fisher, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2321-2326